Skip to content
Screener

Stryker SYK MedSurg and Neurotechnology: — Capital Expenditures During Period

Similar metrics at other companies

Universal Technical Institute logo
UTIChange in accrued capital expenditures during the period
$5.68M+477%
Phillips 66 logo
PSXCapital Expenditures and Investments
$726M+23.7%
ConocoPhillips logo
COPCapital expenditures and investments
$3.02B-8.0%
Imperial Oil logo
IMOCapital and exploration expenditures
$531M+12.3%
WSFS Financial logo
WSFSWealth and Trust — Capital expenditures for the period ended
$0-100%
Mammoth Energy Services, Inc. logo
TUSKSand — Purchased capital expenditures
$700K

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$129.28B-9.8%
Enterprise value$140.08B-11.2%
P/E34.7×-14.5×
P/S-1.0×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept syk:CapitalExpendituresDuringPeriod.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Segment Capital SpendingThree Months / 2026Three Months / 2025
Purchases of property, plant and equipment:
MedSurg and Neurotechnology$58$33
Orthopaedics4149
Total segment purchases of property, plant and equipment$99$82
Corporate and Other6741
Total purchases of property, plant and equipment$166$123

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's medsurg and neurotechnology: — capital expenditures during period?
Stryker (SYK) reported medsurg and neurotechnology: — capital expenditures during period of $58M in Q1 2026.
How has Stryker's medsurg and neurotechnology: — capital expenditures during period changed year-over-year?
Stryker's medsurg and neurotechnology: — capital expenditures during period increased by 75.8% year-over-year, from $33M to $58M.
What is the long-term trend for Stryker's medsurg and neurotechnology: — capital expenditures during period?
Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology: — capital expenditures during period has grown at a 2.8% compound annual growth rate (CAGR), from $197M to $220M.
What does medsurg and neurotechnology: — capital expenditures during period mean?
Measures the cash spent by the MedSurg and Neurotechnology segment to acquire, upgrade, or maintain physical assets such as manufacturing facilities and medical equipment. This reflects the segment's investment in its future production capacity and infrastructure. It is a key indicator of long-term growth strategy and capital intensity.

Ask your AI about Stryker's medsurg and neurotechnology: — capital expenditures during period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude